Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Th17 cells are a distinct lineage of effector CD4+ T cells characterized by their production of interleukin (IL)-17. We demonstrate that Th17 cells also expressed IL-22, an IL-10 family member, at substantially higher amounts than T helper (Th)1 or Th2 cells. Similar to IL-17A, IL-22 expression was initiated by transforming growth factor β signaling in the context of IL-6 and other proinflammatory cytokines. The subsequent expansion of IL-22–producing cells was dependent on IL-23. We further demonstrate that IL-22 was coexpressed in vitro and in vivo with both IL-17A and IL-17F. To study a functional relationship among these cytokines, we examined the expression of antimicrobial peptides by primary keratinocytes treated with combinations of IL-22, IL-17A, and IL-17F. IL-22 in conjunction with IL-17A or IL-17F synergistically induced the expression of β-defensin 2 and S100A9 and additively enhanced the expression of S100A7 and S100A8. Collectively, we have identified IL-22 as a new cytokine expressed by Th17 cells that synergizes with IL-17A or IL-17F to regulate genes associated with skin innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which are induced by IL-17 during infection (see section below) [28,31].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“S100A7 and S100A8 are strongly regulated by IL-17 and IL-22 in keratinocytes.25,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“IL-17A and IL-22 are two members of the cytokine family with substantial roles in host defense and other immunoregulatory functions.25,36,39,69–72”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
In the citing paper
“IL-22, another product of Th17 cells, appears to be protective in the bleomycin model (150)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [150]
In the citing paper
“IL-1, TNFα, IFNγ, IL-17, and IL-22 are strong inducers of hBD2 and hBD3 expression.25,36,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · cited 1×
“Also, IL-23p19–defi cient mice are very susceptible to Citrobacter rodentium infection despite maintaining wild-type expression of IL-17A (7).”
BackgroundInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 2×
“Similar to IL-17A and IL-17F, IL-22 induces IL-6, CXCL8, and MCP-1 expression by fi broblast cells (1, 13, 14).”
BackgroundAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669 · cited 1×
“For example, IL-23p19–defi cient mice are completely resistant to disease in collagen-induced arthritis, whereas IL-17A– defi cient mice remain susceptible, albeit with a signifi cantly reduced incidence and severity (9, 10).”
BackgroundIL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359 · cited 7×
“Keratinocytes treated with a combination of IL-17A and IL-17F enhanced S100A8, but did not further enhance expression of hBD-2, S100A7, or S100A9.”
BackgroundInfluential
Cited by
Items 201–300 of 1,006
Th17 cells and mucosal host defense
Aujla, S. J., Dubin, P. J., & Kolls, J. K. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.009 · Cited by 304
“Recently it has been shown that IL-22 a product of Th17 cells synergizes with IL-17 in inducing these antimicrobial proteins in human keratinocytes which lends further support of the T-cell lineage in mucosal immunity [46].”
BackgroundTargeting IL-10 Family Cytokines for the Treatment of Human Diseases
Wang, X., Wong, K., Ouyang, W., & Rutz, S. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028548 · Cited by 302
“All IL-20 subfamily members, except IL-26, induce the expression of various antimicrobial peptides, including S100 family genes and β-defensin family genes (Boniface et al. 2005; Liang et al. 2006; Wolk et al. 2006; Sa et al. 2007).”
BackgroundThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“While IL-22, another product of Th17 cells, appears to be protective in the bleomycin model (150) BAL concentrations do not differ between IPF and control (151).”
BackgroundInterleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 300
“S100A7, S100A8, S100A9, LL-37, and DEFB4A are anti-microbial peptides, and their expression is upregulated by IL-17A in keratinocytes [190,210,211].”
BackgroundSong, X., Zhu, S., Shi, P., Liu, Y., Shi, Y., Levin, S. D., & Qian, Y. (2011) · Nature Immunology · doi:10.1038/ni.2155 · Cited by 312
“Furthermore, IL-17A or IL-17F acts together with IL-22 to synergistically or additively induce antibacterial peptides in keratinocyte”
BackgroundPlasticity of Human CD4 T Cell Subsets
Geginat, J., Paroni, M., Maglie, S., Alfen, J. S., Kastirr, I., Gruarin, P., De Simone, M., Pagani, M., & Abrignani, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00630 · Cited by 292
“IL-22, a cytokine that promotes epithelial proliferation and barrier function (121), is produced by some Th17 cells (122, 123), and IL-22 and IL-17 co-operate to control gram-negative bacteria in the lung (124).”
BackgroundNew Treatment Addressing the Pathogenesis of Psoriasis
Tokuyama, M., & Mabuchi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207488 · Cited by 291
“The combination of IL22, IL17A, IL17F, and keratinocytes synergistically induced the expression of β-defensin 2, S100A9, S100A7, and S100A8 [12].”
BackgroundSabat, R. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.11.001 · Cited by 298
“IL-22 can be produced by socalled Th22 [30,31], Th1 [29], and Th17 [32,33] cells.”
BackgroundTh17 cells: a new fate for differentiating helper T cells
Chen, Z., & O’Shea, J. J. (2008) · Immunologic Research · doi:10.1007/s12026-007-8014-9 · Cited by 300
“recognized that IL-23 and not IL-12 is the culprit, at least in many of the animal models [25–30].”
BackgroundInfluentialCarlson, M. J., West, M. L., Coghill, J. M., Panoskaltsis-Mortari, A., Blazar, B. R., & Serody, J. S. (2009) · Blood · doi:10.1182/blood-2008-06-162420 · Cited by 302
Tillack, C., Ehmann, L. M., Friedrich, M., Laubender, R. P., Papay, P., Vogelsang, H., Stallhofer, J., Beigel, F., Bedynek, A., Wetzke, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-302853 · Cited by 302
Hernández, P. P., Mahlakõiv, T., Yang, I., Schwierzeck, V., Nguyen, N., Guendel, F., Gronke, K., Ryffel, B., Hölscher, C., Dumoutier, L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3180 · Cited by 287
“IL-22 can be produced by group 3 innate lymphoid cells (ILC3s) 29 , T helper 17 (T H 17) cells 30 , subsets of γδ T cells 31 and possibly neutrophils 32 .”
A role for T cell-derived interleukin 22 in psoriatic skin inflammation
Boniface, K., Guignouard, E., Pedretti, N., Garcia, M., Delwail, A., Bernard, F.-X., Nau, F., Guillet, G., Dagregorio, G., Yssel, H., et al. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03511.x · Cited by 290
Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
Jäger, A., & Kuchroo, V. K. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02432.x · Cited by 282
Schoenborn, J. R., Dorschner, M. O., Sekimata, M., Santer, D. M., Shnyreva, M., Fitzpatrick, D. R., Stamatoyannopoulos, J. A., & Wilson, C. B. (2007) · Nature Immunology · doi:10.1038/ni1474 · Cited by 293
“, unlike IFN-γ, IL-22 is highly expressed by IL-17-producing T helper cells rather than T H 1 cell”
BackgroundInterleukin-23/Th17 pathways and inflammatory bowel disease
Abraham, C., & Cho, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20894 · Cited by 289
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
Van Belle, A. B., de Heusch, M., Lemaire, M. M., Hendrickx, E., Warnier, G., Dunussi-Joannopoulos, K., Fouser, L. A., Renauld, J.-C., & Dumoutier, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102224 · Cited by 287
“As it was shown previously that blocking IL-17 prevents the development of skin lesions in this imiquimod model, our data suggest that IL-17 and IL-22, which are both induced by IL-23 in vivo, exert synergistic activities in skin inflammation, in line with their in vitro activity on keratinocyte cultures (8).”
BackgroundInfluentialSelf-citationThe Innate Immune System in Acute and Chronic Wounds
MacLeod, A. S., & Mansbridge, J. N. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0608 · Cited by 289
“S100A7 and S100A8 are strongly regulated by IL-17 and IL-22 in keratinocytes.(25,39)”
BackgroundIL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?
Lubberts, E. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.014 · Cited by 289
“However, it matters whether IL-23 is present in addition to TGF-b and IL-6 regarding the cytokine profile expressed by Th17 cells [59,60].”
BackgroundHijnen, D., Knol, E. F., Gent, Y. Y., Giovannone, B., Beijn, S. J. P., Kupper, T. S., Bruijnzeel-Koomen, C. A. F. M., & Clark, R. A. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.456 · Cited by 271
“IL-17-producing T cells have a critical role in protecting the skin from extracellular pathogens, and cytokines produced by these cells lead to upregulation of antimicrobial peptide production by keratinocytes (Liang et al., 2006).”
BackgroundA novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses
Chang, S. H., & Dong, C. (2007) · Cell Research · doi:10.1038/cr.2007.35 · Cited by 280
Muñoz, M., Heimesaat, M. M., Danker, K., Struck, D., Lohmann, U., Plickert, R., Bereswill, S., Fischer, A., Dunay, I. R., Wolk, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090900 · Cited by 277
“Furthermore, IL-22 induces the expression of antimicrobial peptides in epithelial cells (Liang et al., 2006; Aujla et al., 2007; Zheng et al., 2008).”
BackgroundNiyonsaba, F., Ushio, H., Hara, M., Yokoi, H., Tominaga, M., Takamori, K., Kajiwara, N., Saito, H., Nagaoka, I., Ogawa, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900712 · Cited by 282
The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut
Wang, C., Kang, S. G., Lee, J., Sun, Z., & Kim, C. H. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.84 · Cited by 278
Regulatory role of short-chain fatty acids in inflammatory bowel disease
Zhang, Z., Zhang, H., Chen, T., Shi, L., Wang, D., & Tang, D. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00869-5 · Cited by 259
“Moreover, IL22 also enhances AMP expression and improves the ability of the gut to resist bacterial translocation [100].”
BackgroundCrome, S. Q., Wang, A. Y., & Levings, M. K. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04037.x · Cited by 275
Th17 T cells: Linking innate and adaptive immunity
Stockinger, B., Veldhoen, M., & Martin, B. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.008 · Cited by 271
Deriu, E., Boxx, G. M., He, X., Pan, C., Benavidez, S. D., Cen, L., Rozengurt, N., Shi, W., & Cheng, G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005572 · Cited by 280
“The host inflammatory response against Salmonella in the gut [50] includes the synthesis of antimicrobial peptides, some of which may possess a secondary function as regulatory molecules [51].”
BackgroundWolk, K., Witte, E., Hoffmann, U., Doecke, W.-D., Endesfelder, S., Asadullah, K., Sterry, W., Volk, H.-D., Wittig, B. M., & Sabat, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5973 · Cited by 270
“In a very recent study, IL-17A and IL-17F were shown to have similar effects and act synergistically with IL-22 on keratinocytes and colonic subepithelial myofibroblasts with respect to the induction of antimicrobial protein ( -defensin 2 and S100 proteins) expression and cytokine (IL-6, IL-8, IL-11, and leukemia-inhi…”
BackgroundArck, P., Hansen, P. J., Mulac Jericevic, B., Piccinni, M., & Szekeres‐Bartho, J. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00512.x · Cited by 274
Th17 Cell Plasticity and Functions in Cancer Immunity
Guéry, L., & Hugues, S. (2015) · BioMed Research International · doi:10.1155/2015/314620 · Cited by 261
“Moreover, and together with IL-22, IL-17 induces antimicrobial peptides and proteins (β-defensins and S100 proteins) production by keratinocytes [17].”
BackgroundImmune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Th17 cytokines and mucosal immunity
Dubin, P. J., & Kolls, J. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00703.x · Cited by 244
“They have also shown that there is greater induction of IL-22 under Th1 cell differentiation conditions compared with Th2 cell differentiation conditions and still greater production by Th17 cells (45, 54, 55); this has been demonstrated at both the mRNA and the protein levels.”
BackgroundRedox signaling in the gastrointestinal tract
Pérez, S., Taléns-Visconti, R., Rius-Pérez, S., Finamor, I., & Sastre, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.048 · Cited by 273
Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation
Chen, Z., Laurence, A., & O'Shea, J. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.015 · Cited by 274
Th17 Immunity in Patients with Allergic Asthma
Zhao, Y., Yang, J., Gao, Y.-D., & Guo, W. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000250438 · Cited by 264
Lochner, M., Ohnmacht, C., Presley, L., Bruhns, P., Si-Tahar, M., Sawa, S., & Eberl, G. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100052 · Cited by 254
“We suggest that RORt+ cells, including Th17 cells and IL-22– producing NKp46+ cells, limit DSS-induced intestinal inflammatory disease by strengthening antibacterial immunity, such as the production of antibacterial peptides by epithelial cells (Liang et al., 2006).”
BackgroundInfluentialSchuetz, A., Deleage, C., Sereti, I., Rerknimitr, R., Phanuphak, N., Phuang-Ngern, Y., Estes, J. D., Sandler, N. G., Sukhumvittaya, S., Marovich, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004543 · Cited by 262
“Mucosal Th17 cells express a wide range of functions compared to those in blood including the production of IL-22, IL-17A, IL17F, IL-1, IL-2 and IL-21 that together induce the expression of defensins and other antibacterial products [48].”
BackgroundIL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani
Pitta, M. G. R., Romano, A., Cabantous, S., Henri, S., Hammad, A., Kouriba, B., Argiro, L., el Kheir, M., Bucheton, B., Mary, C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38813 · Cited by 265
Colin, E. M., Asmawidjaja, P. S., van Hamburg, J. P., Mus, A. M. C., van Driel, M., Hazes, J. M. W., van Leeuwen, J. P. T. M., & Lubberts, E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25043 · Cited by 270
CD4 T-cell differentiation and inflammatory bowel disease
Zenewicz, L. A., Antov, A., & Flavell, R. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.03.002 · Cited by 266
Human Langerhans cells induce distinct IL-22-producing CD4 + T cells lacking IL-17 production
Fujita, H., Nograles, K. E., Kikuchi, T., Gonzalez, J., Carucci, J. A., & Krueger, J. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911472106 · Cited by 254
“In addition, this cytokine has much stronger effects in regulating hyperplasia and differentiation in keratinocytes (7, 12, 13, 15).”
BackgroundResultS100A8/A9 Proteins Mediate Neutrophilic Inflammation and Lung Pathology during Tuberculosis
Gopal, R., Monin, L., Torres, D., Slight, S., Mehra, S., McKenna, K. C., Fallert Junecko, B. A., Reinhart, T. A., Kolls, J., Báez-Saldaña, R., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0803oc · Cited by 255
“Consistent with our findings, IL-17 independently and synergistically with IL-22 can also induce S100 A7, A8, A9 mRNA in human keratinocytes (25).”
BackgroundResultIL-22 defines a novel immune pathway of antifungal resistance
De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, J.-C., Bistoni, F., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.22 · Cited by 265
Shen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
“IL-17 activates IL-6 synergistically with other cytokines, including IL-1b, IFNc, TNFa and most recently IL-22 [25,71–74].”
BackgroundInfluentialCD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease
Gomez-Bris, R., Saez, A., Herrero-Fernandez, B., Rius, C., Sanchez-Martinez, H., & Gonzalez-Granado, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032696 · Cited by 245
Agak, G. W., Qin, M., Nobe, J., Kim, M.-H., Krutzik, S. R., Tristan, G. R., Elashoff, D., Garbán, H. J., & Kim, J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.334 · Cited by 253
“In addition to IL-17A and F, Th17 cells produce IL-6, IL-21 and IL-22 and exhibit effector functions distinct from the Th1 and Th2 cells (Harrington et al. , 2005; Langrish et al. , 2005; Liang et al. , 2006; Nurieva et al. , 2007; Park et al. , 2005; Zheng et al. , 2007; Zhou et al. , 2007).”
Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies
Ahluwalia, B., Moraes, L., Magnusson, M. K., & Öhman, L. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1447597 · Cited by 241
“However, further investigation of the protective role of IL-17A in human studies is required to confirm this hypothesis [91,92].”
BackgroundRole of gut microbiota in infectious and inflammatory diseases
Maciel-Fiuza, M. F., Muller, G. C., Campos, D. M. S., do Socorro Silva Costa, P., Peruzzo, J., Bonamigo, R. R., Veit, T., & Vianna, F. S. L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1098386 · Cited by 233
“IL-22 acts in the maintenance of intestinal epithelial cells (IECs), regulates the equilibrium of the commensal microbiota and protects against infection by Citrobacter rodentium (Liang et al., 2006; Su et al., 2022).”
BackgroundLai, Y., Li, D., Li, C., Muehleisen, B., Radek, K. A., Park, H. J., Jiang, Z., Li, Z., Lei, H., Quan, Y., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.010 · Cited by 261
“For example, IL-22 and IL-17 enhance the expression of antimicrobial peptides S100A7 and S100A8 in keratinocytes (Liang et al., 2006).”
BackgroundWolk, K., Warszawska, K., Hoeflich, C., Witte, E., Schneider-Burrus, S., Witte, K., Kunz, S., Buss, A., Roewert, H. J., Krause, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903907 · Cited by 254
“Among T cells, IL-22 was described to be produced by the Th1 (25), Th17 (16, 39), and very recently by the Th22 (40, 41) cell subsets.”
BackgroundInfluentialInterleukin‐17 as an Effector Molecule of Innate and Acquired Immunity against Infections
Matsuzaki, G., & Umemura, M. (2007) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2007.tb04008.x · Cited by 258
IL-17 contributes to CD4-mediated graft-versus-host disease
Kappel, L. W., Goldberg, G. L., King, C. G., Suh, D. Y., Smith, O. M., Ligh, C., Holland, A. M., Grubin, J., Mark, N. M., Liu, C., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172155 · Cited by 256
The role of the novel Th17 cytokine IL-26 in intestinal inflammation
Dambacher, J., Beigel, F., Zitzmann, K., De Toni, E. N., Göke, B., Diepolder, H. M., Auernhammer, C. J., & Brand, S. (2009) · Gut · doi:10.1136/gut.2007.130112 · Cited by 245
Th17 Cytokines and the Gut Mucosal Barrier
Blaschitz, C., & Raffatellu, M. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9368-7 · Cited by 248
“Expression of the S100A8 and S100A9 subunits of calprotectin is induced in the mucosa in response to IL-17 and IL-22 stimulation [34, 94].”
BackgroundHajishengallis, G., & Korostoff, J. M. (2017) · Periodontology 2000 · doi:10.1111/prd.12181 · Cited by 241
“In summary, while T-helper 17 cells and interleukin-17 have the capacity to mediate protective responses, the current burden of evidence from human and animal model studies suggests that their net effect promotes disease development, whereas the opposite effect (protection) appears to be facilitated by regulatory T-ce…”
BackgroundDevelopment and characterization of IL-21–producing CD4+ T cells
Suto, A., Kashiwakuma, D., Kagami, S.-I., Hirose, K., Watanabe, N., Yokote, K., Saito, Y., Nakayama, T., Grusby, M. J., Iwamoto, I., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072057 · Cited by 246
Update on psoriasis immunopathogenesis and targeted immunotherapy
Mahil, S. K., Capon, F., & Barker, J. N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-015-0539-8 · Cited by 245
“IL22 has been shown to act in synergy with IL-17A to induce AMP production by keratinocytes [120].”
BackgroundDalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V., Clément, K., et al. (2014) · Diabetes · doi:10.2337/db13-1511 · Cited by 240
Zhong, Z., Su, G., Kijlstra, A., & Yang, P. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100866 · Cited by 247
γδ T cells protect against lung fibrosis via IL-22
Simonian, P. L., Wehrmann, F., Roark, C. L., Born, W. K., O'Brien, R. L., & Fontenot, A. P. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100061 · Cited by 242
“Emerging data suggest that IL-22 may provide mucosal protection by inducing antimicrobial peptides from epithelial cells in the lung, gut, and skin as well as maintaining epithelial integrity either by preventing injury or accelerating epithelial repair after a variety of insults (Liang et al., 2006; Zheng et al., 200…”
BackgroundEyerich, K., Foerster, S., Rombold, S., Seidl, H.-P., Behrendt, H., Hofmann, H., Ring, J., & Traidl-Hoffmann, C. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.139 · Cited by 243
“IL-17-producing T cells represent a recently described T-cell subset characterized by production of IL-17 and IL-22 (Liang et al., 2006; Bettelli et al., 2007).”
BackgroundEyerich, K., Pennino, D., Scarponi, C., Foerster, S., Nasorri, F., Behrendt, H., Ring, J., Traidl-Hoffmann, C., Albanesi, C., & Cavani, A. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.031 · Cited by 246
Witte-Händel, E., Wolk, K., Tsaousi, A., Irmer, M. L., Mößner, R., Shomroni, O., Lingner, T., Witte, K., Kunkel, D., Salinas, G., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.11.018 · Cited by 239
“Because IL-17A and TNF-a also showed elevated expressions in HS lesions (Figure 1b) and both are well known for their cooperative actions with other mediators (Carrier et al., 2011; Liang et al., 2006; Wolk et al., 2009), we next tested for the synergistic potential of these cytokines with IL-1b.”
BackgroundAntimicrobial peptides in the pathogenesis of psoriasis
MORIZANE, S., & GALLO, R. L. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01483.x · Cited by 237
GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival
Sonderegger, I., Iezzi, G., Maier, R., Schmitz, N., Kurrer, M., & Kopf, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071119 · Cited by 238
Th17 cytokines and their emerging roles in inflammation and autoimmunity
Fouser, L. A., Wright, J. F., Dunussi‐Joannopoulos, K., & Collins, M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00712.x · Cited by 246
“LPS-stimulated dendritic cells can support IL-23-dependent production of IL-22 from antigen-stimulated naive T cells in the absence of additional exogenous cytokines (7).”
BackgroundInfluentialSelf-citationGeboes, L., Dumoutier, L., Kelchtermans, H., Schurgers, E., Mitera, T., Renauld, J., & Matthys, P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24220 · Cited by 235
Chapter 3 Cellular and Molecular Mechanisms in Atopic Dermatitis
Oyoshi, M. K., He, R., Kumar, L., Yoon, J., & Geha, R. S. (2009) · Advances in Immunology · doi:10.1016/s0065-2776(09)01203-6 · Cited by 241
“A marked synergistic effect between IL-17 and IL-22, another cytokine produced by Th17 cells, was observed on IL-8 and AMP production while IL-4 and IL-13 inhibited IL-17 mediated HBD-2 induction (Eyerich et al., 2008; Liang et al., 2006).”
BackgroundKirkham, B. W., Kavanaugh, A., & Reich, K. (2014) · Immunology · doi:10.1111/imm.12142 · Cited by 243
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
Buchert, M., Burns, C. J., & Ernst, M. (2016) · Oncogene · doi:10.1038/onc.2015.150 · Cited by 243
IL-17 and Th17 cells in human inflammatory diseases
Miossec, P. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.003 · Cited by 236
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
Kunkl, M., Frascolla, S., Amormino, C., Volpe, E., & Tuosto, L. (2020) · Cells · doi:10.3390/cells9020482 · Cited by 232
“IL-21 provides a positive-feedback loop for successful amplification of the Th17 cell subset [49], and IL-22 acts on epithelial cells favoring the production of antimicrobial peptides and mucus [50].”
BackgroundCecchinato, V, Trindade, C. J., Laurence, A., Heraud, J. M., Brenchley, J. M., Ferrari, M. G., Zaffiri, L., Tryniszewska, E., Tsai, W. P., Vaccari, M., et al. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.14 · Cited by 242
ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation
Pearson, C., Thornton, E. E., McKenzie, B., Schaupp, A.-L., Huskens, N., Griseri, T., West, N., Tung, S., Seddon, B. P., Uhlig, H. H., et al. (2016) · eLife · doi:10.7554/elife.10066 · Cited by 233
“By contrast, double blockade of IL-17A and IL-22 reduced colitis severity, indicating that these cytokines may play a redundant role in driving intestinal inflammation possibly through shared effects on intestinal epithelial cells (Liang et al., 2006).”
BackgroundCD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire
de Jong, A., Peña-Cruz, V., Cheng, T.-Y., Clark, R. A., Van Rhijn, I., & Moody, D. B. (2010) · Nature Immunology · doi:10.1038/ni.1956 · Cited by 231
“In mice, IL-22 is often detected in T H 17 cells 45 , but human T cells known as ‘IL-22 only’ or T H 22 cells can produce IL-22 in the absence of IL-17 46–49 .”
Witte, E., Witte, K., Warszawska, K., Sabat, R., & Wolk, K. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.08.002 · Cited by 233
“Interestingly, whereas the keratinocyte influence of IL-22 was shared by other T cell cytokines such as IFN-g and IL-17 with respect to antimicrobial protein induction (IL-17, IFN-g) [26,65] and MMP induction (IFN-g) [23], it was not shared with respect to its influence on the keratinocyte terminal differentiation [94…”
BackgroundLineage-specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T Cells
Palmer, M. T., Lee, Y. K., Maynard, C. L., Oliver, J. R., Bikle, D. D., Jetten, A. M., & Weaver, C. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163790 · Cited by 241
IL-23–Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
Rizzo, H. L., Kagami, S., Phillips, K. G., Kurtz, S. E., Jacques, S. L., & Blauvelt, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001001 · Cited by 238
IL-17 and IL-22: siblings, not twins
Eyerich, S., Eyerich, K., Cavani, A., & Schmidt-Weber, C. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.004 · Cited by 236
Precarious Balance: Th17 Cells in Host Defense
Peck, A., & Mellins, E. D. (2010) · Infection and Immunity · doi:10.1128/iai.00929-09 · Cited by 236
The cutaneous innate immune response in patients with atopic dermatitis
Kuo, I.-H., Yoshida, T., De Benedetto, A., & Beck, L. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1563 · Cited by 231
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S., & Dayer, J.-M. (2008) · Blood · doi:10.1182/blood-2008-05-155408 · Cited by 235
CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
Hedrick, M. N., Lonsdorf, A. S., Shirakawa, A.-K., Lee, C.-C. R., Liao, F., Singh, S. P., Zhang, H. H., Grinberg, A., Love, P. E., Hwang, S. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37378 · Cited by 238
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Gaffen, S. L. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0052-y · Cited by 235
Signaling of interleukin-17 family cytokines in immunity and inflammation
Chang, S. H., & Dong, C. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.022 · Cited by 229
Multiple impacts of zinc on immune function
Haase, H., & Rink, L. (2014) · Metallomics · doi:10.1039/c3mt00353a · Cited by 237
How Diverse--CD4 Effector T Cells and their Functions
Wan, Y. Y., & Flavell, R. A. (2009) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp001 · Cited by 222
“Later study found that TGF-b together with IL-6, which alone induces IL-22 (Zheng et al., 2007), promoted the generation of Th7 cells and showed further that addition of IL-6 suppressed the TGF-b-induced generation of Foxp3 þ Treg while reciprocally promoting the generation of Th17 cells (Bettelli et al., 2006; Mangan…”
BackgroundTape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis
He, H., Bissonnette, R., Wu, J., Diaz, A., Saint-Cyr Proulx, E., Maari, C., Jack, C., Louis, M., Estrada, Y., Krueger, J. G., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.048 · Cited by 229
Wang, C. Q. F., Akalu, Y. T., Suarez-Farinas, M., Gonzalez, J., Mitsui, H., Lowes, M. A., Orlow, S. J., Manga, P., & Krueger, J. G. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.237 · Cited by 232
“Although IL-17 can induce pro-inflammatory cytokines by itself, its effects are vastly increased when cooperating with TNF (Liang et al., 2006).”
BackgroundWüthrich, M., Deepe, G. S., & Klein, B. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074958 · Cited by 224
“In mucosal infection models, IL-17 prompts keratinocytes and epithelial cells to release antimicrobial peptides (AMPs), such as S100A proteins, b-defensins, and histatins that show direct killing activity (Liang et al. 2006; Conti et al. 2011).”
Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment
Guttman‐Yassky, E., Krueger, J. G., & Lebwohl, M. G. (2018) · Experimental Dermatology · doi:10.1111/exd.13336 · Cited by 225
Matejuk, A. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0477-3 · Cited by 206
“Expression of AMPs can be upregulated by some pro-inflammatory cytokines such as interleukin IL-17 and IL-22 (Liang et al. 2006).”
BackgroundInfluentialA new vision of immunity: homeostasis of the superorganism
Eberl, G. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.20 · Cited by 224
Signal transduction pathways and transcriptional regulation in Th17 cell differentiation
Hirahara, K., Ghoreschi, K., Laurence, A., Yang, X.-P., Kanno, Y., & O'Shea, J. J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.006 · Cited by 219
“One includes cells that selectively produce IL-17 (Th17 cells) [5–10].”
The Th17 family: flexibility follows function
Basu, R., Hatton, R. D., & Weaver, C. T. (2013) · Immunological Reviews · doi:10.1111/imr.12035 · Cited by 229
“IL-22 is a cytokine of the IL-10 family that is often regarded as a signature product of Th17 cells (57, 58).”
BackgroundInterleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells
Gu, Y., Yang, J., Ouyang, X., Liu, W., Li, H., Yang, J., Bromberg, J., Chen, S., Mayer, L., Unkeless, J. C., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200838331 · Cited by 221
“Th17 cells, which secrete interleukin 17 (IL-17) and IL-22, comprise a recently identified subset of CD4+ T cells that is distinct from Th1 and Th2 subsets [1–4].”
BackgroundKeratinocyte: A trigger or an executor of psoriasis?
Ni, X., & Lai, Y. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0120-439r · Cited by 218
Czarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., Khattri, S., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.020 · Cited by 221
Metadata
- Authors
- Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A.
- Affiliations
- 1Inflammation
- 2Antibody Technologies Group, Wyeth Research, Cambridge, MA 02140
- Wyeth (US)
- ORCID
- Collins, Mary
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-09-18
- Volume
- 203
- Issue
- 10
- Pages
- 2271-2279
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118116
- OpenAlex
- W2139008734
- Cited by
- 2,330
- References
- 19
- Citations by year
- 2026: 57 · 2025: 61 · 2024: 80 · 2023: 74 · 2022: 93 · 2021: 118 · 2020: 127 · 2019: 104 · 2018: 104 · 2017: 112 · 2016: 126 · 2015: 132 · 2014: 145 · 2013: 147 · 2012: 156
- FWCI
- 47.05
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- IL-22, IL-17A, IL-17F, Th17 cells, antimicrobial peptides, human beta-defensin 2, S100A7, S100A8, S100A9, keratinocytes, skin innate immunity, IL-23, interleukin-6, TGF-beta signaling, cytokine synergy
- MeSH terms
- Interleukin-22, Animals, Cell Differentiation, Immunity, Innate, Interleukins, Mice, Transgenic, Signal Transduction, CD4-Positive T-Lymphocytes, Keratinocytes, Polymerase Chain Reaction, Transforming Growth Factor beta, Interleukin-17, Antimicrobial Cationic Peptides, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.